Experts call trial results of medication that slowed cognitive decline by almost a third ‘very promising’

A pill that mimics Viagra by relaxing blood vessels and increasing blood flow to the brain can slow cognitive decline in people with Alzheimer’s disease by almost a third, a global study suggests.

Alzheimer’s is the most common form of dementia, a condition that is forecast to affect 153 million people worldwide by 2050. There is currently no cure.

In a stage three trial spanning 13 countries, including the UK, researchers found the tablet AR1001 slowed decline by 31% in patients with early Alzheimer’s disease not receiving any other treatment.

Experts

  • WhoIzDisIz@lemmy.today
    link
    fedilink
    English
    arrow-up
    10
    ·
    3 days ago

    In a wider group of patients taking other drugs, the tablet did not achieve statistically significant results.

    So just an alternative option to existing treatments, with the only added benefit apparently being that it’s easier to take since it’s oral. That’s good, but I don’t see any real reason for excitement. This seems more like marketing.

    • Onomatopoeia@lemmy.cafe
      link
      fedilink
      English
      arrow-up
      3
      arrow-down
      1
      ·
      3 days ago

      I agree it seems like msrketing.

      I’d be curious to know the risk structure of this drug compared to the other drugs, does this drug equal efficacy of other drugs combined, and how the risk profiles compare.

      There’s a lot not answered in this article, and the risk profile is far overlooked or minimized for everything in my opinion.